Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for HIND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.0015M
September 30, 2024 -0.0012M
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 -0.003M
March 31, 2023 -0.007M
December 31, 2022 -0.079M
September 30, 2022 -0.033M
June 30, 2022 0.018M
March 31, 2022 0.002M
December 31, 2021 -3.067M
September 30, 2021 -0.089M
Date Value
June 30, 2021 5.13M
March 31, 2021 -0.119M
December 31, 2020 -2.16M
September 30, 2020 -0.148M
June 30, 2020 0.244M
March 31, 2020 -0.326M
December 31, 2019 -0.15M
September 30, 2019 -0.024M
June 30, 2019 -0.001M
March 31, 2019 2.531M
December 31, 2018 5.185M
September 30, 2018 -7.317M
June 30, 2018 -1.295M
March 31, 2018 22.94M
December 31, 2017 17.86M
September 30, 2017 13.27M
June 30, 2017 -30.08M
March 31, 2017 -22.91M
December 31, 2016 9.207M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cardiac Biotech Solutions, Inc. 0.00
Anika Therapeutics, Inc. -1.28M
Enovis Corp. -45.01M
Edwards Lifesciences Corp. -193.20M
Perspective Therapeutics, Inc. 15.02M